30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Argos Therapeutics Inc (ARGSQ)

Track

Stock chart
Ticker: ARGSQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Katz Richard D
Vice President and CFO
1 sale — total 17,200 USD
Planned sale 9 Jan 2018
Value US$219,334.91 | Price 42.05 | Shares 96,370
Planned sale 9 Jan 2018
Value US$1,213,555.73 | Price 335.60 | Shares 54,319
Planned sale 9 Jan 2018
Value US$20,572.86 | Price 0.16 | Shares 124,987
Planned sale 9 Jan 2018
Value US$16,501.15 | Price 0.16 | Shares 100,250
Planned sale 3 Jan 2018
Value US$9,658.27 | Price 0.16 | Shares 59,072
Planned sale 3 Jan 2018
Value US$18,719.37 | Price 0.16 | Shares 114,702
Planned sale 3 Jan 2018
Value US$18,719.37 | Price 0.16 | Shares 114,702
Planned sale 3 Jan 2018
Value US$16,540.66 | Price 0.16 | Shares 101,228
Planned sale 3 Jan 2018
Value US$15,060.56 | Price 0.16 | Shares 92,001
Buy 7 Oct 2016
Value US$99,330.00 | Price 4.73 | Shares 21,000
Buy 6 Oct 2016
Value US$12,698.40 | Price 4.81 | Shares 2,640
Buy 5 Oct 2016
Value US$4,365.00 | Price 4.85 | Shares 900
Buy 4 Oct 2016
Value US$33,599.16 | Price 4.69 | Shares 7,164
Buy 3 Oct 2016
Value US$53,147.60 | Price 4.70 | Shares 11,308
Buy 30 Sep 2016
Value US$142,392.72 | Price 4.71 | Shares 30,232
Buy 29 Sep 2016
Value US$69,460.00 | Price 4.60 | Shares 15,100
Buy 28 Sep 2016
Value US$129,471.72 | Price 4.54 | Shares 28,518
Buy 20 Sep 2016
Value US$196,805.43 | Price 4.77 | Shares 41,259
Buy 19 Sep 2016
Value US$26,560.80 | Price 4.76 | Shares 5,580
Buy 16 Sep 2016
Value US$175,100.96 | Price 4.78 | Shares 36,632
Buy 15 Sep 2016
Value US$75,588.80 | Price 4.76 | Shares 15,880
Buy 1 Sep 2016
Value US$81,150.06 | Price 4.78 | Shares 16,977
Buy 24 Aug 2016
Value US$252,373.68 | Price 4.57 | Shares 55,224
Buy 24 Aug 2016
Value US$262,862.60 | Price 4.55 | Shares 57,772
Buy 23 Aug 2016
Value US$41,851.64 | Price 4.36 | Shares 9,599
Buy 22 Aug 2016
Value US$93,507.00 | Price 4.26 | Shares 21,950
Buy 19 Aug 2016
Value US$226,406.52 | Price 4.23 | Shares 53,524
Buy 2 Aug 2016
Value US$0.00 | Price 0.00 | Shares 1,545,454
Buy 2 Aug 2016
Value US$0.00 | Price 0.00 | Shares 2,363,636
Buy 2 Aug 2016
Value US$0.00 | Price 0.00 | Shares 1,545,454
Buy 29 Jun 2016
Value US$0.00 | Price 0.00 | Shares 275,545
Buy 29 Jun 2016
Value US$0.00 | Price 0.00 | Shares 1,322,618
Buy 29 Jun 2016
Value US$0.00 | Price 0.00 | Shares 2,678,301
Buy 29 Jun 2016
Value US$0.00 | Price 0.00 | Shares 1,322,618
Buy 14 Mar 2016
Value US$0.00 | Price 0.00 | Shares 183,697
Buy 14 Mar 2016
Value US$0.00 | Price 0.00 | Shares 881,745
Buy 14 Mar 2016
Value US$0.00 | Price 0.00 | Shares 1,785,534
Buy 16 Dec 2015
Value US$9,000.00 | Price 1.80 | Shares 5,000
Buy 16 Dec 2015
Value US$457.50 | Price 1.83 | Shares 250
Buy 15 Dec 2015
Value US$4,300.00 | Price 2.15 | Shares 2,000
Buy 14 Dec 2015
Value US$12,486.00 | Price 2.50 | Shares 5,000
Buy 14 Dec 2015
Value US$107.46 | Price 2.15 | Shares 50
Buy 14 Dec 2015
Value US$214.50 | Price 2.15 | Shares 100
Buy 14 Dec 2015
Value US$214.58 | Price 2.15 | Shares 100
Buy 24 Nov 2015
Value US$21,250.00 | Price 4.25 | Shares 5,000
Buy 24 Nov 2015
Value US$21,500.00 | Price 4.30 | Shares 5,000
Buy 19 Nov 2015
Value US$41,511.00 | Price 4.15 | Shares 10,000
Buy 19 Nov 2015
Value US$4,080.00 | Price 4.08 | Shares 1,000
Buy 3 Sep 2015
Value US$37,843.20 | Price 6.31 | Shares 6,000
Buy 2 Sep 2015
Value US$37,341.60 | Price 6.22 | Shares 6,000
Buy 1 Sep 2015
Value US$31,318.00 | Price 6.26 | Shares 5,000
Buy 25 Aug 2015
Value US$15,352.75 | Price 6.14 | Shares 2,500
Buy 24 Aug 2015
Value US$609.00 | Price 6.09 | Shares 100
Buy 24 Aug 2015
Value US$5,490.00 | Price 6.10 | Shares 900
Buy 20 Aug 2015
Value US$29,023.50 | Price 5.80 | Shares 5,000
Buy 20 Aug 2015
Value US$32,250.00 | Price 6.45 | Shares 5,000
Buy 19 Aug 2015
Value US$14,654.32 | Price 4.73 | Shares 3,100
Buy 19 Aug 2015
Value US$26,149.20 | Price 4.75 | Shares 5,500
Buy 12 Feb 2014
Value US$291,328.00 | Price 8.00 | Shares 36,416
Buy 12 Feb 2014
Value US$323,976.00 | Price 8.00 | Shares 40,497
Buy 12 Feb 2014
Value US$10,200,000.00 | Price 8.00 | Shares 1,275,000
Buy 12 Feb 2014
Value US$318,984.00 | Price 8.00 | Shares 39,873
Buy 12 Feb 2014
Value US$291,328.00 | Price 8.00 | Shares 36,416
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-01-12 2018-01-09 PlS Planned sale Katz Richard D

Vice President and CFO

Officer
96,370 +45.0%
42.05
US$219,335 		96,370 +45.0% 42.05 US$219,335
2018-01-12 2018-01-09 PlS Planned sale Harrelson Lori R.

Vice President of Finance

Officer
54,319 +12.5%
335.60
US$1,213,556 		54,319 +12.5% 335.60 US$1,213,556
2018-01-12 2018-01-09 PlS Planned sale Abbey Jeffrey D

President, CEO

Executive Director
49,765 +13.1%
211.50
US$3,516,129 		49,765 +13.1% 211.50 US$3,516,129
2018-01-12 2018-01-09 PlS Planned sale Nicolette Charles A.

CSO and Vice President of R&D

Officer
100,250 -20.0%
0.16
US$16,501 		100,250 -20.0% 0.16 US$16,501
2018-01-05 2018-01-03 PlS Planned sale Harrelson Lori R.

Vice President of Finance

Officer
59,072 -16.7%
0.16
US$9,658 		59,072 -16.7% 0.16 US$9,658
2018-01-05 2018-01-03 PlS Planned sale Abbey Jeffrey D

President, CEO

Executive Director
114,702 -15.3%
0.16
US$18,719 		114,702 -15.3% 0.16 US$18,719
2018-01-05 2018-01-03 PlS Planned sale Abbey Jeffrey D

President, CEO

Executive Director
114,702 -15.3%
0.16
US$18,719 		114,702 -15.3% 0.16 US$18,719
2018-01-05 2018-01-03 PlS Planned sale Katz Richard D

Vice President and CFO

Officer
101,228 -25.3%
0.16
US$16,541 		101,228 -25.3% 0.16 US$16,541
2018-01-05 2018-01-03 PlS Planned sale Nicolette Charles A.

CSO and Vice President of R&D

Officer
92,001 -15.5%
0.16
US$15,061 		92,001 -15.5% 0.16 US$15,061
2016-10-13 2016-10-07 B Purchase Pharmstandard International S.A. Large shareholder
21,000 +0.2%
4.73
US$99,330 		21,000 +0.2% 4.73 US$99,330
2016-10-13 2016-10-06 B Purchase Pharmstandard International S.A. Large shareholder
2,640 +0.0%
4.81
US$12,698 		2,640 +0.0% 4.81 US$12,698
2016-10-13 2016-10-05 B Purchase Pharmstandard International S.A. Large shareholder
900 +0.0%
4.85
US$4,365 		900 +0.0% 4.85 US$4,365
2016-10-13 2016-10-04 B Purchase Pharmstandard International S.A. Large shareholder
7,164 +0.1%
4.69
US$33,599 		7,164 +0.1% 4.69 US$33,599
2016-10-04 2016-10-03 B Purchase Pharmstandard International S.A. Large shareholder
11,308 +0.1%
4.70
US$53,148 		11,308 +0.1% 4.70 US$53,148
2016-10-04 2016-09-30 B Purchase Pharmstandard International S.A. Large shareholder
30,232 +0.2%
4.71
US$142,393 		30,232 +0.2% 4.71 US$142,393
2016-09-30 2016-09-29 B Purchase Pharmstandard International S.A. Large shareholder
15,100 +0.1%
4.60
US$69,460 		15,100 +0.1% 4.60 US$69,460
2016-09-30 2016-09-28 B Purchase Pharmstandard International S.A. Large shareholder
28,518 +0.2%
4.54
US$129,472 		28,518 +0.2% 4.54 US$129,472
2016-09-21 2016-09-20 B Purchase Pharmstandard International S.A. Large shareholder
41,259 +0.3%
4.77
US$196,805 		41,259 +0.3% 4.77 US$196,805
2016-09-21 2016-09-19 B Purchase Pharmstandard International S.A. Large shareholder
5,580 +0.0%
4.76
US$26,561 		5,580 +0.0% 4.76 US$26,561
2016-09-20 2016-09-16 B Purchase Pharmstandard International S.A. Large shareholder
36,632 +0.3%
4.78
US$175,101 		36,632 +0.3% 4.78 US$175,101
2016-09-20 2016-09-15 B Purchase Pharmstandard International S.A. Large shareholder
15,880 +0.1%
4.76
US$75,589 		15,880 +0.1% 4.76 US$75,589
2016-09-07 2016-09-01 B Purchase Pharmstandard International S.A. Large shareholder
16,977 +0.1%
4.78
US$81,150 		16,977 +0.1% 4.78 US$81,150
2016-08-29 2016-08-24 B Purchase Pharmstandard International S.A. Large shareholder
55,224 +0.4%
4.57
US$252,374 		55,224 +0.4% 4.57 US$252,374
2016-08-25 2016-08-24 B Purchase Pharmstandard International S.A. Large shareholder
57,772 +0.4%
4.55
US$262,863 		57,772 +0.4% 4.55 US$262,863
2016-08-25 2016-08-23 B Purchase Pharmstandard International S.A. Large shareholder
9,599 +0.1%
4.36
US$41,852 		9,599 +0.1% 4.36 US$41,852
2016-08-23 2016-08-22 B Purchase Pharmstandard International S.A. Large shareholder
21,950 +0.2%
4.26
US$93,507 		21,950 +0.2% 4.26 US$93,507
2016-08-23 2016-08-19 B Purchase Pharmstandard International S.A. Large shareholder
53,524 +0.4%
4.23
US$226,407 		53,524 +0.4% 4.23 US$226,407
2016-08-04 2016-08-02 B Purchase van Deventer Sander Non-Executive Director Large shareholder
1,545,454
0.00
US$0 		1,545,454 0.00 US$0
2016-08-04 2016-08-02 B Purchase Pharmstandard International S.A. Large shareholder
2,363,636
0.00
US$0 		2,363,636 0.00 US$0
2016-08-04 2016-08-02 B Purchase ForArgos B.V. Large shareholder
1,545,454
0.00
US$0 		1,545,454 0.00 US$0
2016-07-01 2016-06-29 B Purchase Birner Hubert Non-Executive Director
275,545
0.00
US$0 		275,545 0.00 US$0
2016-07-01 2016-06-29 B Purchase van Deventer Sander Non-Executive Director Large shareholder
1,322,618
0.00
US$0 		1,322,618 0.00 US$0
2016-07-01 2016-06-29 B Purchase Pharmstandard International S.A. Large shareholder
2,678,301
0.00
US$0 		2,678,301 0.00 US$0
2016-07-01 2016-06-29 B Purchase ForArgos B.V. Large shareholder
1,322,618
0.00
US$0 		1,322,618 0.00 US$0
2016-03-16 2016-03-14 B Purchase
Birner Hubert
Non-Executive Director
183,697
0.00
US$0 		183,697 0.00 US$0
2016-03-16 2016-03-14 B Purchase
van Deventer Sander
Non-Executive Director Large shareholder
881,745
0.00
US$0 		881,745 0.00 US$0
2016-03-16 2016-03-14 B Purchase Pharmstandard International S.A. Large shareholder
1,785,534
0.00
US$0 		1,785,534 0.00 US$0
2015-12-17 2015-12-16 B Purchase Petrov Andrei Vladimirovich Non-Executive Director
5,000 +inf%
1.80
US$9,000 		5,000 +inf% 1.80 US$9,000
2015-12-17 2015-12-16 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
250 +100.0%
1.83
US$458 		250 +100.0% 1.83 US$458
2015-12-16 2015-12-15 B Purchase Vinogradov Alexey Alexandrovich Non-Executive Director
2,000 +inf%
2.15
US$4,300 		2,000 +inf% 2.15 US$4,300
2015-12-17 2015-12-14 B Purchase Abbey Jeffrey D

CEO

Executive Director
5,000 +90.9%
2.50
US$12,486 		5,000 +90.9% 2.50 US$12,486
2015-12-16 2015-12-14 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
50 +25.0%
2.15
US$107 		50 +25.0% 2.15 US$107
2015-12-16 2015-12-14 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
100 +100.0%
2.15
US$214 		100 +100.0% 2.15 US$214
2015-12-16 2015-12-14 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
100 +inf%
2.15
US$215 		100 +inf% 2.15 US$215
2015-11-25 2015-11-24 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +12.5%
4.25
US$21,250 		5,000 +12.5% 4.25 US$21,250
2015-11-25 2015-11-24 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +14.2%
4.30
US$21,500 		5,000 +14.2% 4.30 US$21,500
2015-11-23 2015-11-19 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
10,000 +39.8%
4.15
US$41,511 		10,000 +39.8% 4.15 US$41,511
2015-11-23 2015-11-19 B Purchase Abbey Jeffrey D

CEO

Executive Director
1,000 +18.2%
4.08
US$4,080 		1,000 +18.2% 4.08 US$4,080
2015-09-04 2015-09-03 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
6,000 +31.4%
6.31
US$37,843 		6,000 +31.4% 6.31 US$37,843
2015-09-04 2015-09-02 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
6,000 +45.8%
6.22
US$37,342 		6,000 +45.8% 6.22 US$37,342
2015-09-02 2015-09-01 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +61.7%
6.26
US$31,318 		5,000 +61.7% 6.26 US$31,318
2015-08-26 2015-08-25 B Purchase Lamarre Jean Non-Executive Director
2,500 +inf%
6.14
US$15,353 		2,500 +inf% 6.14 US$15,353
2015-08-27 2015-08-24 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
100 +11.1%
6.09
US$609 		100 +11.1% 6.09 US$609
2015-08-27 2015-08-24 B Purchase Winterbottom Joan

Chief Human Resources Officer

Officer
900 +inf%
6.10
US$5,490 		900 +inf% 6.10 US$5,490
2015-08-27 2015-08-20 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
5,000 +161.3%
5.80
US$29,024 		5,000 +161.3% 5.80 US$29,024
2015-08-27 2015-08-20 B Purchase Nicolette Charles A.

Chief Scientific Officer

Officer
5,000 +61.5%
6.45
US$32,250 		5,000 +61.5% 6.45 US$32,250
2015-08-27 2015-08-19 B Purchase Van Holle Philippe Marie Marcel Joseph Non-Executive Director
3,100 +inf%
4.73
US$14,654 		3,100 +inf% 4.73 US$14,654
2015-08-21 2015-08-19 B Purchase Abbey Jeffrey D

CEO

Executive Director
5,500 +inf%
4.75
US$26,149 		5,500 +inf% 4.75 US$26,149
2014-02-12 2014-02-12 B Purchase Cooperatieve AAC LS U.A. Large shareholder
36,416 +1.5%
8.00
US$291,328 		36,416 +1.5% 8.00 US$291,328
2014-02-12 2014-02-12 B Purchase Underdown Brian J. Non-Executive Director Large shareholder
40,497 +3.3%
8.00
US$323,976 		40,497 +3.3% 8.00 US$323,976
2014-02-12 2014-02-12 B Purchase Pharmstandard International S.A. Large shareholder
1,275,000 +27.1%
8.00
US$10,200,000 		1,275,000 +27.1% 8.00 US$10,200,000
2014-02-12 2014-02-12 B Purchase Birner Hubert Non-Executive Director Large shareholder
39,873 +2.8%
8.00
US$318,984 		39,873 +2.8% 8.00 US$318,984
2014-02-12 2014-02-12 B Purchase van Deventer Sander Non-Executive Director Large shareholder
36,416 +1.5%
8.00
US$291,328 		36,416 +1.5% 8.00 US$291,328
Explore more

More insider trading research around Argos Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America